Trial · NCT01494532
Adverse events96
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 96
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Constipation | Gastrointestinal disorders | Treatment Group A: Placebo | 4 | 75 | |
| other | Constipation | Gastrointestinal disorders | Treatment Group B: 4 mg/Day | 0 | 25 | |
| other | Constipation | Gastrointestinal disorders | Treatment Group C: 8 mg/Day | 0 | 76 | |
| other | Constipation | Gastrointestinal disorders | Treatment Group D: 12 mg/Day | 0 | 75 | |
| other | Constipation | Gastrointestinal disorders | Treatment Group E: 16 mg/Day | 0 | 76 | |
| other | Constipation | Gastrointestinal disorders | Treatment Group F: 24 mg/Day | 0 | 25 | |
| other | Nausea | Gastrointestinal disorders | Treatment Group A: Placebo | 8 | 75 | |
| other | Nausea | Gastrointestinal disorders | Treatment Group B: 4 mg/Day | 1 | 25 | |
| other | Nausea | Gastrointestinal disorders | Treatment Group C: 8 mg/Day | 5 | 76 | |
| other | Nausea | Gastrointestinal disorders | Treatment Group D: 12 mg/Day | 8 | 75 | |
| other | Nausea | Gastrointestinal disorders | Treatment Group E: 16 mg/Day | 7 | 76 | |
| other | Nausea | Gastrointestinal disorders | Treatment Group F: 24 mg/Day | 2 | 25 | |
| other | Nasopharyngitis | Infections and infestations | Treatment Group A: Placebo | 1 | 75 | |
| other | Nasopharyngitis | Infections and infestations | Treatment Group B: 4 mg/Day | 0 | 25 | |
| other | Nasopharyngitis | Infections and infestations | Treatment Group C: 8 mg/Day | 2 | 76 | |
| other | Nasopharyngitis | Infections and infestations | Treatment Group D: 12 mg/Day | 2 | 75 | |
| other | Nasopharyngitis | Infections and infestations | Treatment Group E: 16 mg/Day | 0 | 76 | |
| other | Nasopharyngitis | Infections and infestations | Treatment Group F: 24 mg/Day | 2 | 25 | |
| other | Fall | Injury, poisoning and procedural complications | Treatment Group A: Placebo | 4 | 75 | |
| other | Fall | Injury, poisoning and procedural complications | Treatment Group B: 4 mg/Day | 0 | 25 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01494532/events